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Abstract
Introduction: Our aim was to evaluate the safety and efficacy of a low-intensity resistance training program combined
with partial blow flow restriction (BFR training) in a cohort of patients with polymyositis (PM) and dermatomyositis (DM).
Methods: In total, 13 patients with PM and DM completed a 12-week twice a week low-intensity (that is, 30% one-
repetition-maximum (1RM)) resistance exercise training program combined with partial blood flow restriction (BFR).
Assessments of muscle strength, physical function, quadriceps cross sectional (CSA) area, health-related quality of life, and
clinical and laboratory parameters were assessed at baseline and after the intervention.
Results: The BFR training program was effective in increasing the maximal dynamic strength in both the leg-press
(19.6%, P <0.001) and knee-extension exercises (25.2% P <0.001), as well as in the timed-stands (15.1%, P <0.001) and
timed-up-and-go test (−4.5%, P =0.002). Quadriceps CSA was also significantly increased after the intervention (4.57%,
P =0.01). Similarly, all of the components of the Short Form-36 Health Survey, the Health Assessment Questionnaire scores,
and the patient- and physician reported Visual Analogue Scale were significantly improved after training (P <0.05).
Importantly, no clinical evidence or any other self-reported adverse event were found. Laboratory parameters (creatine
kinase and aldolase) were also unchanged (P >0.05) after the intervention.
Conclusions: We demonstrated that a 12-week supervised low-intensity resistance training program associated with
partial blood flow restriction may be safe and effective in improving muscle strength and function as well as muscle mass
and health-related quality of life in patients with PM and DM.
Trial registration: Clinicaltrials.gov NCT01501019. Registered November 29, 2011.
Introduction
Polymyositis (PM) and dermatomyositis (DM) are part of
a group of rare conditions named idiopathic inflammatory
myositis (IIM) that are characterized by proximal muscle
weakness [1] as well as muscle atrophy, fatigue, myalgia,
and impairment in distal lower-limb muscle function,
[2,3]. Collectively, these features lead to limitations in ac-
tivities of daily living and poor quality of life [4,5].
In this regard, physical exercise, specifically resistance
exercise training, has been proposed as a safe and effective
therapeutic tool to counteract several of the symptoms re-
lated to muscle dysfunction in patients with PM and DM
[6-8]. In fact, resistance training has been shown to im-
prove isometric peak torque, muscle strength, muscle en-
durance, functional capacity, and quality of life in PM and
DM patients [6,8-12]; however, only one study has investi-
gated the benefits of this exercise modality on increase in
muscle mass in PM/DM patients, with the results showing
significant improvements in type-II fiber cross-sectional
area (CSA) [13].
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Importantly, exercise intensities within the 70% to 85%
of one-repetition-maximum (1RM) range have been rec-
ommended for increases in muscle mass and strength
[14]. Alternatively, low-intensity resistance training (for
example, 20% to 30% 1RM) combined with partial blood
flow restriction (BFR) induces similar gains in muscle
mass and strength as compared to conventional high-
intensity resistance training in different populations (for
example, athletes, healthy young adults, and the elderly)
[15-20]. The clinical application of this intervention has
the potential to represent an interesting approach to re-
sistance exercise in IIM, as patients are often unable to
exercise at high intensities. In fact, BFR training has
been previously shown to increase muscle strength, bal-
ance, quality of life, and thigh CSA in one patient with
inclusion body myositis [21]. However, there are no
studies applying BRF training in a cohort of patients
with PM/DM patients. Therefore, the aim of the present
study was to evaluate the safety and efficacy of a BFR
training program in a cohort of patients with PM and
DM.
Methods
Study design and patients
This prospective, longitudinal, quasi-experimental study
was conducted between 2011 and 2013 in São Paulo,
Brazil (Clinical Hospital, School of Medicine, University
of São Paulo). This study was registered at clinicaltrials.gov
as NCT01501019.
Thirty-seven patients with non-active PM and DM
from our outpatient clinic were eligible to participate in
this trial and only 15 accepted the invitation to take part
in the study. Two patients withdrew before the com-
mencement of the study due to personal reasons. There-
fore, 13 patients (9 women and 4 men) completed the
protocol and were evaluated (age 45.6 ± 8.8 years; BMI
31.0 ± 6.6 kg/m2; peak oxygen consumption (VO2peak)
23.3 ± 6.9 mL/kg/min). Figure 1 shows the flow chart for
the protocol. All of the patients were diagnosed with
definite PM/DM according to the Bohan and Peter cri-
teria [22]. Exclusion criteria included: acute or chronic
infection; other untreated chronic disease (for example,
hepatic, kidney, endocrine and/or cardiac involvement);
physical limitations that could preclude the participation
in the physical tests and training; and active disease. The
patients were not engaged in any form of exercise for at
least six months prior to the study, and 12 out of the 13
patients had never had any previous experience with
regular exercise. The only exception is one patient who
had been enrolled in a resistance exercise routine (two
times a week for 3 months) 2.5 years prior to the
commencement of the present study. The study was
approved by the Local Ethical Committee (School of
Medicine, University of São Paulo) and all of the patients
signed the written informed consent form. Table 1
shows the patients’ main features and the drug regime.
At baseline (PRE) and after the intervention (POST),
independent assessors evaluated health-related quality of
life, muscle strength and function, quadriceps CSA, and
laboratory and clinical parameters.
Exercise training program
The exercise program consisted of a twice-weekly 12-
week supervised BFR training program (that is, low-
intensity resistance exercises combined with partial blood
flow restriction). Exercise sessions were monitored by at
least two fitness professionals and were performed in an
intrahospital gymnasium (Laboratory of Assessment and
Conditioning in Rheumatology, Clinical Hospital, School
of Medicine, University of São Paulo, Brazil). The BFR
training program was comprised of conventional two-
legged leg-press (Nakagym®, São Paulo, Brazil) and knee
extension (Nakagym®) exercises. The restriction in blood
flow was obtained by placing an air cuff (width 175 mm×
length 920 mm) at the inguinal fold of both thighs, as pre-
viously described [23]. A partial blood-flow restriction was
sustained throughout the entire training sessions (25 to
30 minutes), including the rest intervals and it was re-
leased immediately after the end of the training sessions.
During the first 4 weeks of training, patients were required
to perform four sets of 15 repetitions with 30% 1RM. Dur-
ing the first week, a reduced intensity of 20% 1RM for
each exercise was performed. From the fifth week on, ex-
ercise volume was increased to five sets of 15 repetitions
with 30% 1RM. Exercise load was adjusted every 4 weeks
by reassessment of the patients’ 1RM and a 1-minute rest
period was allowed between sets throughout the entire
training protocol. A member of the research staff moni-
tored the adherence to the exercise program on a session
Figure 1 Flowchart of the protocol for the patients with
polymyositis and dermatomyositis.
Mattar et al. Arthritis Research & Therapy 2014, 16:473 Page 2 of 8
http://arthritis-research.com/content/16/5/473
basis. The patients completed an average of 22.6 ± 3 out of
the 24 exercise sessions originally planned (94 ± 9% adher-
ence rate).
Determination of the blood flow restriction pressure
Before the commencement of the training protocol, blood
flow restriction pressure was determined. Subjects were
asked to comfortably lie supine while a vascular Doppler
probe (DV-600, Marted, Ribeirão Preto, SP, Brazil) was
placed over the tibial artery to capture its auscultatory
pulse. The blood pressure (mmHg) necessary for the
complete blood flow restriction (pulse elimination pres-
sure) was determined by attaching a standard blood pres-
sure cuff to the participant’s thigh (inguinal fold region)
and then inflating it up to the point in which the ausculta-
tory pulse was interrupted [23]. The cuff pressure utilized
during the training protocol was determined as 70% of the
predetermined pulse elimination pressure. A mean of 94
± 13 mmHg of cuff pressure was utilized during the exer-
cise sessions. For visual details on the procedures for the
determination of blood flow restriction pressure and ad-
ministration of the low-resistance training combined with
partial blood flow restriction, please refer to a previous de-
scription of the methods [23].
Muscle strength and physical function assessments
The patients underwent two familiarization sessions sepa-
rated by at least 72 h for their assessment of 1RM. The
1RM tests were performed for the leg-press and knee ex-
tension exercises according to previously described criteria
[24]. In brief, prior to the 1RM test, two light warm-up
sets were performed with 2 minutes interspersed. Then,
the patients had up to five attempts to achieve the 1RM
load, with a 3-minute interval between attempts. Verbal
encouragement was provided and testing sessions were
conducted by two experienced researchers.
Physical function was assessed by the timed-stands test
(TST) and the timed up-and-go test (TUG). The TST
evaluates the maximum number of stand-ups that a sub-
ject can perform from a standard-height (that is, 45 cm)
armless chair within 30 seconds, whereas TUG evaluates
the time that is required for the subject to rise from a
standard arm chair, walk towards a line drawn on the
floor three meters away, turn, return, and sit back down
again. The coefficients of variation (CV) for the muscle
function tests were 3.0%, 4.1%, 2.6%, and 1.7% for the
1RM leg press, 1RM knee extension, TST, and TUG,
respectively.
Quadriceps CSA
Magnetic resonance imaging (MRI) was used to obtain
quadriceps CSA (Signa LX 9.1, GE Healthcare, Milwaukee,
WI, USA). Patients lay in a supine position with their
knees extended and legs straight. A bandage was used to
restrain leg movements during the test. An initial refer-
ence image was obtained to determine the perpendicular
distance from the greater trochanter of the femur to the
inferior border of the lateral epicondyle of the femur,
which was defined as the segment length. Quadriceps
CSA was measured at 50% of the segment length with
0.8 cm slices for 3 seconds. The pulse sequence was per-
formed with a view field between 400 and 420 mm, repeti-
tion time of 350 milliseconds, echo time from 9 to 11
milliseconds, two signal acquisitions, and matrix of re-
construction of 256 × 256. The quadriceps images were
traced in triplicates by a specialized researcher, and
Table 1 Patients’ characteristics and drug regimen
Patients (disease) BMI, kg/m2 Disease duration, months Current use of immunosuppressant drugs
I (DM) 30.5 61 AZA
II (DM) 38.6 60 CQ; MTX; CP
III (DM) 38.2 151 None
IV (PM) 27.9 23 AZA
V (DM) 21.4 75 CQ; CP
VI (DM) 26.5 52 AZA; MTX; Prednisone
VII (PM) 31.4 99 MTX 15
VIII (PM) 32.4 26 AZA; MTX
IX (DM) 23.5 82 MTX
X (DM) 27.4 37 HCQ; AZA
XI (PM) 25.2 38 MMF
XII (DM) 43.0 93 AZA
XIII (DM) 37.7 48 AZA
All patients, mean (SD) 31 (6.6) 65 (35) Not applicable
DM, dermatomyositis; PM, polymyositis; BMI, body mass index; AZA, azathioprine; CQ, chloroquine diphosphate; MTX, methotrexate; CP, cyclosporine; HCQ,
hydroxychloroquine sulphate; MMF, mycophenolate mofetil.
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their mean values were used for further analysis. The
between-measurements CV was 0.6%.
Quality of life and limitation of daily activities
assessments
The short form-36 health survey (SF-36) was used to as-
sess health-related quality of life before and after the
BRF training program. A maximal score of 100 indicates
the best health condition. The health assessment ques-
tionnaire (HAQ) assessed limitation of daily activities
with scores ranging from 0 to 3, where the minimal
score indicates the best health condition.
Clinical and laboratory assessments
Clinical and laboratory assessments were performed at
baseline and after the exercise training program. Safety
analysis included the assessment of laboratory parameters
of inflammation (creatine kinase (CK) and aldolase) before
the commencement of the training protocol and 48 h after
the last training session. Additionally, patients’ and physi-
cians’ global assessment subscales from the visual analog
scale (VAS) were also assessed. The patients were advised
to report any sort of adverse events and potential disease-
flare episodes were monitored throughout the study. Fi-
nally, all of the patients were examined by a rheumatolo-
gist on a weekly basis throughout the intervention in
order to evaluate any possible symptoms of excessive ex-
haustion, pain, osteoarticular injury, muscle soreness, or
any other adverse event.
Maximal-graded cardiorespiratory test
Before the trial, all of the subjects underwent a maximal
graded cardiorespiratory test on a treadmill (Centurion
200, Micromed, Brasilia, Brazil) for VO2peak determination
at baseline. VO2 and carbon dioxide output were obtained
through breath-by-breath sampling and expressed as a
30-second average using an indirect calorimetry system
(Cortex - model Metalyzer III B, Leipzig, Germany).
Heart rate was continuously recorded at rest, during ex-
ercise and at recovery, using a 12-lead electrocardiogram
(Ergo PC Elite, InC. Micromed). VO2peak was considered
as the average of the final 30 seconds of the test. Attain-
ment of VO2peak was considered to be when two of three
criteria were met at the volitional exhaustion: VO2 plateau
(that is, <150 mL/minute increase between two consecu-
tive stages), heart rate (HR) no less than 10 beats below
age-predicted maximal HR, respiratory exchange ratio
value above 1.10, and rating of perceived exertion ≥17 of
the 15-point Borg scale [25].
Statistical analysis
Data are expressed as mean ± SD. The paired t-test was
used to assess possible differences between pre- and
post-intervention periods. Effect sizes (ES) for all of the
dependent variables were calculated according to a
previous description [26]. The Wilcoxon test was ap-
plied to non-parametric data (that is, SF-36, HAQ and
VAS data). The significance level was previously set at
P ≤0.05.
Results
Muscle strength and physical function
The BFR training program was effective in increasing
the 1RM in both the leg-press and the knee-extension
exercises as observed by improvements of 19.6% (ES
0.42, P <0.001) and 25.2% (ES 0.87, P <0.001), respect-
ively. We also observed significant improvements in the
TST scores (15.1%; ES 0.87; P <0.001) and TUG scores
(−4.5%; ES: −0.29; P =0.002) after the intervention
(Figure 2).
Quadriceps CSA
One patient missed the follow-up analysis for quadriceps
CSA, therefore, our data shows results from 12 patients.
The quadriceps CSA was significantly increased after the
BFR training program (4.57%; ES 0.21; P =0.01). Im-
portantly, 10 out of the 12 patients analyzed showed
improvements in CSA above that of the CV of the meas-
urement after the intervention. Figure 3 shows the quad-
riceps CSA data.
Quality of life and limitation of daily activities
assessments
Health-related quality of life measured by the SF-36 was
significantly improved in all of its components after the
intervention. Similarly, the HAQ scores and both the
patient- and physician-reported VAS were also signifi-
cantly improved after the BFR training program (P <0.05
for all of the variables). Table 2 shows the quality of life
and limitation of daily activities data. Importantly, no ad-
verse effects from the blood-flow restriction protocol
(for example, excessive fatigue or pain) were reported by
any of the subjects.
Safety analysis and clinical and laboratory assessments
No clinical evidence of excessive fatigue, pain, osteoarti-
cular injury, muscle soreness, or any other self-reported
adverse event was found. Laboratory parameters were
unchanged after the intervention (CK PRE versus POST,
195 ± 76 versus 224 ± 171 IU/L, respectively; P =0.405;
aldolase PRE versus POST, 3.9 ± 1.5 versus 4.1 ± 1.6 IU/L;
P =0.592). The drug regimen (that is, number, type and
dose of medications) remained unchanged throughout the
study.
Discussion
This was the first study to investigate the effects of low-
intensity resistance training combined with partial BFR
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in a cohort of PM and DM patients. This exercise mode
was shown to be effective in counteracting important
symptoms in PM/DM, including muscle weakness, muscle
dysfunction, muscle atrophy, and poor health-related qual-
ity of life. Of note, no exacerbation of the disease was ob-
served. Collectively, these data provide evidence suggesting
that BFR training may be both safe and effective for non-
active patients with PM and DM.
The beneficial effects of conventional resistance train-
ing in patients with PM and DM have been previously
demonstrated [10,11]. Alexanderson et al. [10] reported
in a pilot study that 12 weeks of home-based resistance
training was effective in increasing muscle endurance
and quality of life in PM and DM patients, while no ad-
verse effects were observed. In accordance, the same re-
search group [11] demonstrated that a similar training
protocol was safe and effective in improving function
and quality of life in PM and DM patients with active
disease. This findings have been corroborated by others
[6,12,27], however, to our knowledge, only one study has
evaluated the effects of resistance training on muscle
mass in patients with PM and DM [13]. Following a 12-
week home-based physical training program, significant
increases (25%) in type-II, but not in type-I fiber CSA
were reported in these patients.
Importantly, increases in muscle mass and strength usu-
ally require high-intensity resistance training, with loads
varying between 70% and 85% 1RM [14]. As IIM are char-
acterized by remarkable impairments in muscle strength
and function, these patients are often unable to exercise at
higher intensities, warranting the need for alternative exer-
cise strategies aiming to increase muscle strength and
mass while minimizing exercise intensity. In this context,
low-intensity strength training associated with BFR has
emerged as an interesting therapeutic tool to these pa-
tients, as it has been shown to induce similar gains in
muscle strength and mass to those observed after conven-
tional high-intensity resistance training [15-20]. The puta-
tive mechanisms for the positive effects of BFR training
Figure 2 Muscle strength and physical function data at baseline (PRE) and after 12 weeks of intervention (POST). (A) Leg-press exercise
one-repetition-maximum (1RM) data; (B) knee-extension exercise 1RM data; (C) timed-stands test (TST) data; (D): timed up-and-go test (TUG) data.
*P <0.05 when compared with baseline assessments.
Figure 3 Quadriceps cross-sectional area (CSA) at baseline
(PRE) and after 12 weeks of intervention (POST). *P <0.05 when
compared with baseline assessments.
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have been attributed to the augmented metabolic stress in-
duced by the diminished blood flow, which may poten-
tially lead to: i) increased muscle fiber recruitment during
exercise [28,29]; ii) elevated systemic hormonal production
[30,31]; iii) enhanced muscle protein synthesis via in-
creased phosphorylation of key proteins involved in
muscle trophism signaling [32,33].
To our knowledge, no study except for a case report
from our group [21] has evaluated the effects of BFR train-
ing in IIM. In this regard, we have previously shown the
potential of this exercise modality in improving muscle
strength and thigh CSA in one patient with inclusion body
myositis. These observations were confirmed and ex-
tended to PM and DM in the current study.
The BFR training program was also able to signifi-
cantly improve lower-limb maximal muscle strength and
muscle function. Impairment in activities of daily living
due to proximal and distal muscle weakness is a promin-
ent feature in PM and DM, warranting great clinical
relevance to these findings. Interestingly, these improve-
ments were paralleled by a reduction in the limitations
of daily activities (that is, improvement in HAQ scores),
and improvements in quality of life as observed by im-
proved scores in all of the components of the SF-36 and
both in the patient- and physician-reported VAS.
Another important finding from the present study was
the ability of BFR to increase quadriceps CSA. This is cer-
tainly a relevant outcome as muscle atrophy is an import-
ant feature in IIM and it is closely related to the sustained
disability usually experienced by these patients. The mech-
anisms by which muscle atrophy occurs in IIM are still
not fully understood, but it is thought to involve a vicious
circle comprising muscle disuse and muscle waste along-
side other factors such as inflammation, metabolic dis-
turbances and steroid myopathy [3,34-36]. The current
findings reveal that BFR training may be a suitable thera-
peutic strategy to offset muscle atrophy in PM and DM,
although its underlying mechanisms remain to be fully
solved.
Despite the growing number of studies emphasizing the
safety aspects of exercise in IIM, there is still empirical
concern that exercise could cause disease-flare activity in
IIM. In accordance with previous findings [6,7,10,11] BFR
training induced neither any alteration in the laboratory
markers of safety nor any clinical adverse effects. These
findings certainly add to the accumulated body of evidence
indicating that exercise training programs are safe for PM
and DM patients, extending this notion to BFR training.
This study is not without limitations. The lack of a non-
trained control group can be considered as the main limi-
tation, as the natural course of the disease might have in-
fluenced the outcomes. However, the short-term nature of
this trial, along with the fact that the patients remained in
remission, mitigate this possibility. We acknowledge, how-
ever, that further randomized controlled trials or a within-
subject design with repeated measures would strengthen
our findings. The latter would constitute an interesting ap-
proach in such a heterogeneous rare disease. Another
limitation is the lack of additional markers of disease activ-
ity other than muscle enzymes.
Importantly, as this study involved only non-active pa-
tients, it is not possible to generalize the present findings
to patients with active disease. Further trials with larger
and diversified (for example, active, remissive, refractory)
samples are necessary in order to advance the knowledge
on the effects of BFR in IIM. Likewise, future trials
should explore the intrinsic mechanisms by which BFR
can improve muscle strength, function, and mass in IIM.
Finally, it is imperative to compare the potential of BFR
against traditional heavy-load resistance training.
Table 2 Effects of a 12-week supervised BFR training program on health-related quality of life, limitation of daily
activities and laboratory parameters in patients with polymyositis and dermatomyositis
Variable PRE POST ES % P-value (pre- to post-test)
SF-36 physical function 57.5 ± 23.2 80.4 ± 11.6 1.03 39.82 0.003*
SF-36 role physical 31.3 ± 42.8 62.5 ± 39.2 0.76 99.68 0.041*
SF-36 bodily pain 59.4 ± 11.4 86.9 ± 14.8 2.52 46.29 0.002*
SF-36 general health 71.4 ± 20.1 83.8 1 ± 5.6 0.65 17.36 0.003*
SF-36 vitality 54.6 ± 20.4 84.2 ± 9.3 1.52 54.21 0.003*
SF-36 social function 65.6 ± 33.7 89.6 ± 17.5 0.74 36.58 0.017*
SF-36 role emotional 27.8 ± 44.6 77.8 ± 38.5 1.17 179.85 0.014*
SF-36 mental health 62.3 ± 20.8 79.0 ± 16.9 0.83 26.80 0.007*
HAQ 1.5 ± 1.9 0.6 ± 0.6 −0.49 −60.00 0.004*
VAS patient 3.4 ± 1.4 1.6 ± 1.2 −1.51 −52.94 0.008*
VAS physician 2.6 ± 1.2 1.2 ± 0.6 −1.21 −53.84 0.004*
PRE (baseline) and POST (after the intervention) values are presented as mean ± SD. BFR, low-intensity resistance training combined with partial blood flow restriction;
PM, polymyositis; DM, dermatomyositis; HAQ, health assessment questionnaire; VAS patient, patient-reported visual analog scale; VAS physician, physician-reported visual
analog scale. *P <0.05 when compared with baseline assessments.
Mattar et al. Arthritis Research & Therapy 2014, 16:473 Page 6 of 8
http://arthritis-research.com/content/16/5/473
Conclusion
In summary, we demonstrated that a 12-week supervised
low-intensity resistance training program associated with
partial blood flow restriction can be safe and effective in
improving muscle strength, function, muscle mass, and
health-related quality of life in non-active patients with
PM and DM.
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